View in EDS

Cost‐effectiveness of vorasidenib in treatment of isocitrate dehydrogenase–mutated low‐grade glioma.

Saved in:
Bibliographic Details
Title: Cost‐effectiveness of vorasidenib in treatment of isocitrate dehydrogenase–mutated low‐grade glioma.
Authors: Kessel, Adam C.1 (AUTHOR) kessel.adam@mayo.edu, Kim, Hayeon2 (AUTHOR), Brown, Paul D.1 (AUTHOR), Lehrer, Eric J.1 (AUTHOR), Laack, Nadia N.1 (AUTHOR), Mahajan, Anita1 (AUTHOR), Yan, Elizabeth1 (AUTHOR), Schultz, Sydney E.3 (AUTHOR), Kizilbash, Sani4 (AUTHOR), Neth, Bryan4 (AUTHOR), Sener, Ugur4 (AUTHOR), Waddle, Mark1 (AUTHOR), Breen, William G.1 (AUTHOR), Kowalchuk, Roman O.1 (AUTHOR)
Source: Cancer (0008543X). Jun2026, Vol. 132 Issue 11, p1-8. 8p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first